Abstract
Since 1985, prenatal diagnosis of congenital toxoplasmosis can be reliably performed in women with suspected or confirmed Toxoplasma infection acquired during pregnancy[1]. Availability of this recent diagnostic procedure has profoundly changed the management of congenital infection before birth and more specifically algorithms of decisions regarding prenatal treatment or medical terminations of pregnancy which were previously based mostly on the sole basis of maternal infection. Therefore, termination of pregnancy for maternal infection with Toxoplasma gondii has now become unusual thanks to prenatal diagnosis along with the possibility to treat infected fetus in utero via mother with the combination regimen of pyrimethamine (PYR) and sulfadiazine (SDZ)[2]. These major advances in the field of diagnosis and therapy has allowed to shift indications of medical termination of pregnancy for toxoplasmosis almost exclusively for cases with severe lesions detected by ultrasonography.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Desmonts G, Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Chartier M (1985) Prenatal diagnosis of congenital toxoplasmosis. Lancet 1:500–504
Couvreur J, Thulliez P, Daffos F et al (1991) Foetopathie toxoplasmique. Traitement in utero par l’association pyrimethamine-sulfamides. Arch Fr Pediatr 48:397–403
Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M (1994) Prenatal diagnosis of congenital toxoplasmosis with a polymerase chain reaction test on amniotic fluid. N Engl J Med 331:695–699
Berrebi A, Kobuch WE, Bessières MH et al (1994) Termination of pregnancy for maternal toxoplasmosis. Lancet 344:36–39
Pratlong F, Boulot P, Villena I, Issert I, Tamby I, Cazenave J, Dedet JP (1996) Antenatal diagnosis of congenital toxoplasmosis: evaluation of the biological parameters in a cohort of 286 patients. Br J Obst Gyn 103:552–557
Daffos F, Forestier F, Capella-Pavlovsky M et al (1988) Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 318:271–275
Dupouy-Camet J, Bougnoux ME, Lavareda de Souza S, Thulliez P, Dommergues M, Mandelbrot L, Ancelle T, Tourte-Schaefer C, Benarous R (1992) Comparative value of polymerase chain reaction and conventional biological tests for the prenatal diagnosis of congenital toxoplasmosis. Ann Biol Clin (Paris) 50:315–319
Grover CM, Thulliez P, Remington JS, Boothroyd JC (1990) Rapid prenatal diagnosis of congenital Toxoplasma infection by using polymerase chain reaction on amniotic fluid. J Clin Microbiol 28:2297–2301
Derouin F, Thulliez P, Candolfi E, Daffos F, Forestier F (1988) Early prenatal diagnosis of congenital toxoplasmosis using amniotic fluid samples and tissue culture. Eur J Clin Microbiol Infect Dis 7:423–425
Thulliez P (1990) Toxoplasmose congénitale: résultats de 105 diagnostics prénatals positifs (VIII th ICOPA, Paris). Bull Soc Fr Parasitol 8:1001
Berrebi A, Cohen-Khallas Y, Bessières MH, Rolland M, Sarramon MF, Fournier A (1992) Valeur prédictive des signes non spécifiques d’infection foetale dans la toxoplasmose congénitale. J Gynecol Obstet Biol Reprod (Paris) 21:791–794
Desmonts G, Naot Y, Remington JS (1981) Immunoglobin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol 14:486–491
Bessières MH, Roques C, Berrebi A, Barre V, Cazaux M, Seguela JP (1992) IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol 45:605–608
Decoster A, Darcy F, Caron A et al (1992) Anti-P30 IgA antibodies as prenatal markers of congenital Toxoplasma infection. Clin Exp Immunol 87:310–315
Le Fichoux Y, Marty P, Chan H (1987) Les IgA sériques spécifiques dans le diagnostic de la toxoplasmose. Ann Pediatr 34:375–379
Daffos F, Capella-Pavlovsky M, Forestier F (1985) Fetal blood sampling during pregnancy with use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol 153:655–660
Burg JL, Grover CM, Pouletty P, Boothroyd JC (1989) Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii by polymerase chain reaction. J Clin Microbiol 27:1787–1792
Dupouy-Camet J, Lavareda de Souza S, Bougnoux ME, Mandelbrot L, Hennequin C, Dommergues M, Benarous R, Tourte-Schaefer C (1990) Preventing congenital toxoplasmosis. Lancet ii: 1017–1018
Sawa D, Morris JC, Johnson JD, Holliman RE (1990) Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol 32:25–31
Cazenave J, Forestier F, Bessières MH, Broussin B, Begueret J (1992) Contribution of a new PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenat Diag 12:120–128
Ghidini A, Sepulveda W, Lockwood CJ, Romero R (1993) Complications of fetal blood sampling. Am J Obstet Gynecol 168:1339–1344
Pelloux H, Guy E, Angelici MC, Aspöck H et al (1998) A second european collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams. FEMS Microbiol Letters 165:231–237
Guy EC, Pelloux H, Lappalainen M et al (1996) Interlaboratory comparison of polymerase chain reaction for the detection of Toxoplasma gondii DNA added to samples of amniotic fluids. Eur J Clin Microbiol Infect Dis 15:836–839
Jenum PA, Holberg-Petersen M, Melby KK, Stray-Pedersen B (1998) Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. The norwegian experience. Acta Pathol Microbiol Immunol Scand 106:680–686
Weiss LM, Udem SA, Salgo M, Tanowitz HB, Wittner M (1991) Sensitive and specific detection of Toxoplasma DNA in an experimental murine model: use of Toxoplasma gondii-specific cDNA and the polymerase chain reaction. J Infect Dis 163:108–186
Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, Eng J (1998) Incidence of Toxoplasma gondii infection in 35.940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 36:2900–2906
Gratzl R, Hayde M, Kohlhauser C, Hermon M, Burda G, Strobl W, Pollak A (1998) Follow-up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur J Clin Microbial Infect Dis 17:853–858
Hohlfeld P, Daffos F, Thulliez P et al (1989) Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 115:765–769
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag France
About this paper
Cite this paper
Romand, S., Thulliez, P. (2000). Laboratory diagnosis of fetal toxoplasmosis. In: Ambroise-Thomas, P., Petersen, P.E. (eds) Congenital toxoplasmosis. Springer, Paris. https://doi.org/10.1007/978-2-8178-0847-5_10
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0847-5_10
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-59664-3
Online ISBN: 978-2-8178-0847-5
eBook Packages: Springer Book Archive